Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Michael Adam Fischer, M.D.

Co-Author

This page shows the publications co-authored by Michael Fischer and Daniel Solomon.
Connection Strength

1.232
  1. Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid programs. Arthritis Rheum. 2008 Nov 15; 59(11):1611-7.
    View in: PubMed
    Score: 0.405
  2. Prior authorization policies for selective cyclooxygenase-2 inhibitors in Medicaid: a policy review. Med Care. 2006 Jul; 44(7):658-63.
    View in: PubMed
    Score: 0.343
  3. Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors. N Engl J Med. 2004 Nov 18; 351(21):2187-94.
    View in: PubMed
    Score: 0.307
  4. Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized patients. Arch Intern Med. 2003 Nov 24; 163(21):2585-9.
    View in: PubMed
    Score: 0.072
  5. Acute pancreatitis associated with rofecoxib. Am J Gastroenterol. 2002 Apr; 97(4):1077-8.
    View in: PubMed
    Score: 0.064
  6. Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid. J Bone Miner Res. 2006 May; 21(5):765-71.
    View in: PubMed
    Score: 0.021
  7. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005 Dec 01; 353(22):2335-41.
    View in: PubMed
    Score: 0.021
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.